Impact of the 2012 United States preventive services task force statement on prostate-specific antigen screening: Analysis of urologic and primary care practices

Urology

Volumn 85, Issue 1, 2015, Pages 85-91

  Perez, Tomy Y ^a   Danzig, Matthew R ^a   Ghandour, Rashed A ^a   Badani, Ketan K ^a   Benson, Mitchell C ^a   McKiernan, James M ^a  

^a Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; CANCER SCREENING; CLINICAL EVALUATION; COMPARATIVE STUDY; CONTROLLED STUDY; DIGITAL RECTAL EXAMINATION; FAMILY HISTORY; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; PATIENT REFERRAL; PATIENT RISK; PREVENTIVE HEALTH SERVICE; PREVENTIVE SERVICES TASK FORCE; PRIMARY MEDICAL CARE; PROSTATE BIOPSY; PROSTATE CANCER; RACE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SCREENING TEST; UNITED STATES; BLOOD; EARLY DIAGNOSIS; MIDDLE AGED; PRACTICE GUIDELINE; PRIMARY HEALTH CARE; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDY; STANDARDS; STATISTICS AND NUMERICAL DATA; UROLOGY;

EARLY DETECTION OF CANCER; HUMANS; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PREVENTIVE HEALTH SERVICES; PRIMARY HEALTH CARE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; UNITED STATES; UROLOGY;

EID: 84918767039     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2014.07.072     Document Type: Article

References (30)

1. A.L. Potosky, B.A. Miller, and P.C. Albertsen The role of increasing detection in the rising incidence of prostate cancer JAMA 273 1995 548 552
2. G.L. Andriole, E.D. Crawford, and R.L. Grubb 3rd Mortality results from a randomized prostate-cancer screening trial N Engl J Med 360 2009 1310 1319
3. F.H. Schroder, J. Hugosson, and M.J. Roobol Screening and prostate-cancer mortality in a randomized European study N Engl J Med 360 2010 1320 1328
4. T.J. Wilt, M.K. Brawer, and K.M. Jones Radical prostatectomy versus observation for localized prostate cancer N Engl J Med 367 2012 203 213
5. V.A. Moyer Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement Ann Intern Med 157 2012 120 134
6. US Preventive Services Task Force Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement Ann Intern Med 149 2008 185 191
7. J.S. Ross, R. Wang, and J.B. Long Impact of 2008 US Preventative Services Task Force recommendation to discontinue prostate cancer screening among male Medicare beneficiaries Arch Intern Med 172 2012 1601 1603
8. J.S. Goodwin, A. Tan, and E. Jaramillo Prostate-specific antigen testing in men aged 40-64 years: impact of publication of clinical trials J Natl Cancer Inst 105 2013 743 745
9. J.A. Cohn, C.E. Wang, and J.C. Lakeman Primary care physician PSA screening practices before and after the final U.S. Preventative Services Task Force recommendation Urol Oncol 32 2014 41.e23-30
10. I.M. Thompson, D.P. Ankerst, and C. Chi Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial JNCI 98 2006 529 534
11. A.V. D'Amico, R. Whittington, and S.B. Malkowicz Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer JAMA 280 1998 969 974
12. R.J. Volk, S.K. Linder, and M.A. Kallen Primary care physicians' use of an informed decision-making process for prostate cancer screening Ann Fam Med 11 2013 67 74
13. G.E. Tasian, M.R. Cooperberg, and M.B. Potter PSA screening: determinants of primary-care physician practice patterns Prostate Cancer Prostatic Dis 15 2012 189 194
14. S. Van der Meer, B.J. Kollen, and W.H. Hirdes Impact of the European Randomized Study of Screening for Prostate Cancer (ERSPC) on prostate-specific antigen (PSA) testing by Dutch general practitioners BJU Int 112 2013 26 31
15. C.E. Pollack, G. Noronha, and G.E. Green Primary care providers' response to the US Preventative Services Task Force draft recommendations on screening for prostate cancer Arch Intern Med 172 2012 668 670
16. American Urological Assoication. AUA Disputes Panel's Recommendations on Prostate Cancer Screening. Atlanta: PR Newswire, May 21, 2012. Web. May 24, 2014. http://www.prnewswire.com/news-releases/aua-disputes-panels-recommendations-on-prostate-cancer-screening-152349275.html. Accessed October 20, 2014.
17. A.H. Roshanai, K. Nordin, and G. Berglund Factors influencing primary care physicians' decision to order prostate-specific antigen (PSA) test for men without prostate cancer Acta Oncol 52 2013 1602 1608
18. L.S. Marks, Y. Fradet, and I.L. Deras PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy Urology 69 2007 532 535
19. A. Haese, A. de la Taille, and H. van Poppel Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsy Eur Urol 54 2008 1081 1088
20. R.R. Goode, S.J. Marshall, and M. Duff Use of PCA3 in detecting prostate cancer in initial and repeat prostate biopsy patients Prostate 73 2013 48 53
21. A. de la Taille, J. Irani, and M. Graefen Clinical evaluation of the PCA3 assay in guiding initial biopsy decisions J Urol 185 2011 2119 2125
22. A. Heidenreich, J. Bellmunt, M. Bolla European Association of Urology EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease Eur Urol 59 2011 61 71
23. NCCN Guidelines. Prostate cancer early detection [v.2.2012]. National Comprehensive Cancer Network Web site. http://www.nccn.org/professionals/physician-gls/pdf/prostate-detection.pdf.
24. D.J. Rosario, J.A. Lane, and C. Metcalfe Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study BMJ 344 2012 d7894
25. B.V. Yanke, B.S. Carver, and F.J. Bianco Jr. African-American race is a predictor of prostate cancer detection: incorporation into a pre-biopsy nomogram BJU Int 98 2006 783 787
26. O. Bratt, H. Garmo, and J. Adolfsson Effects of prostate-specific antigen testing on familial prostate cancer risk estimates J Natl Cancer Inst 102 2010 1336 1343
27. G.L. Andriole, D.G. Bostwick, O.W. Brawley REDUCE Study Group Effect of dutasteride on the risk of prostate cancer N Engl J Med 362 2010 1192 1202
28. A. de la Taille, P. Antiphon, and L. Salomon Prospective evaluation of a 21-sample needle biopsy procedure designed to improve the prostate cancer detection rate Urology 61 2003 1181 1186
29. M.V. Meng, E.P. Elkin, and J. DuChane Impact of increased number of biopsies on the nature of prostate cancer identified J Urol 176 2006 63 68
30. H.B. Carter, P.C. Albertsen, and J.B. Michael Early detection of prostate cancer: AUA Guideline J Urol 190 2013 419 426